{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:57:30Z","timestamp":1780991850038,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["A134328"],"award-info":[{"award-number":["A134328"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Assessing the presence and magnitude of antibodies to pathogens and vector-saliva,\n                    <jats:italic>i.e.<\/jats:italic>\n                    , serosurveillance, is a valuable tool to determine actual exposure of individuals to arthropod vectors and vector-borne pathogens under real life conditions. Antibodies to vector saliva proteins have already demonstrated the potential to serve as biomarkers for exposure to mosquitoes. Since various mosquito species can carry pathogens such as\n                    <jats:italic>Plasmodia<\/jats:italic>\n                    and flaviviruses, positive serological responses to mosquito saliva have been associated with a higher risk of infections in human populations in endemic areas. A recently developed novel high-throughput multiplex assay simultaneously measures antibodies to vector saliva and pathogen-specific antigens as a tool to monitor the efficacy of countermeasures such as repellants and prophylactic drugs in travelers and residents of African malaria-endemic countries. In the current study, this panel was adapted to include vector-specific probes prevalent in Southeast Asia and test samples from serial cross-sectional surveys in Cambodia. The results revealed distinct immune signatures indicative of distinct patterns of host-vector contact, i.\n                    <jats:italic>e.,<\/jats:italic>\n                    bite by infected mosquitoes leading to infection or not, or relapse caused by dormant liver-stage parasites. This approach provides a more detailed understanding of exposure dynamics than traditional surveillance methods, while using a single assay. The study establishes the utility of serosurveillance tools for augmenting conventional entomological and serological methods, particularly in low-transmission settings and when rates of infected vectors are low, thus offering a powerful platform for monitoring exposure to vectors and parasites, disease transmission, and evaluating the efficacy of vector control strategies.\n                  <\/jats:p>","DOI":"10.1186\/s12936-026-05920-1","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:25:08Z","timestamp":1777310708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Simultaneous serological assessment of vector and pathogen exposure to support intervention monitoring and understand host\u2013vector interactions"],"prefix":"10.1186","volume":"25","author":[{"given":"Jessica","family":"Bolton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kobylinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyna","family":"Doum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Tatarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"McIver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil F.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke S.","family":"Bergmann-Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"5920_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0169-4758(86)90082-7","volume":"2","author":"C Dye","year":"1986","unstructured":"Dye C. Vectorial capacity: must we measure all its components? Parasitol Today. 1986;2:203\u20139.","journal-title":"Parasitol Today"},{"key":"5920_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007446","volume":"16","author":"SL Wu","year":"2020","unstructured":"Wu SL, S\u00e1nchez C HM, Henry JM, Citron DT, Zhang Q, Compton K, et al. Vector bionomics and vectorial capacity as emergent properties of mosquito behaviors and ecology. PLoS Comput Biol. 2020;16:e1007446.","journal-title":"PLoS Comput Biol"},{"key":"5920_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1475-2875-9-122","volume":"9","author":"AM Shaukat","year":"2010","unstructured":"Shaukat AM, Breman JG, McKenzie FE. Using the entomological inoculation rate to assess the impact of vector control on malaria parasite transmission and elimination. Malar J. 2010;9:122.","journal-title":"Malar J"},{"key":"5920_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-800099-1.00003-X","volume":"84","author":"LS Tusting","year":"2014","unstructured":"Tusting LS, Bousema T, Smith DL, Drakeley C. Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics. Adv Parasitol. 2014;84:151\u2013208.","journal-title":"Adv Parasitol"},{"key":"5920_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-022-05397-2","volume":"15","author":"C Sukkanon","year":"2022","unstructured":"Sukkanon C, Masangkay FR, Mala W, Kotepui KU, Wilairatana P, Chareonviriyaphap T, et al. Prevalence of Plasmodium spp. in Anopheles mosquitoes in Thailand: a systematic review and meta-analysis. Parasit Vectors. 2022;15:285.","journal-title":"Parasit Vectors"},{"key":"5920_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03158-z","volume":"19","author":"RA Ashton","year":"2020","unstructured":"Ashton RA, Prosnitz D, Andrada A, Herrera S, Y\u00e9 Y. Evaluating malaria programmes in moderate- and low-transmission settings: practical ways to generate robust evidence. Malar J. 2020;19:75.","journal-title":"Malar J"},{"key":"5920_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071839","author":"S Chaudhury","year":"2022","unstructured":"Chaudhury S, Bolton JS, Eller LA, Robb M, Ake J, Ngauy V, et al. Assessing prevalence and transmission rates of malaria through simultaneous profiling of antibody responses against Plasmodium and Anopheles antigens. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11071839.","journal-title":"J Clin Med"},{"key":"5920_CR8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73080","author":"EA Kearney","year":"2021","unstructured":"Kearney EA, Agius PA, Chaumeau V, Cutts JC, Simpson JA, Fowkes FJI. Anopheles salivary antigens as serological biomarkers of vector exposure and malaria transmission: A systematic review with multilevel modelling. Elife. 2021. https:\/\/doi.org\/10.7554\/eLife.73080.","journal-title":"Elife"},{"key":"5920_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed10010013","author":"S Chaudhury","year":"2025","unstructured":"Chaudhury S, Bolton JS, Kamau E, Bergmann-Leitner ES. Assessing the feasibility of using a multiplex serological assay to conduct serosurveillance for malaria exposure in deployed military personnel. Trop Med Infect Dis. 2025. https:\/\/doi.org\/10.3390\/tropicalmed10010013.","journal-title":"Trop Med Infect Dis"},{"key":"5920_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/1469-0691.12151","volume":"19","author":"J Maltha","year":"2013","unstructured":"Maltha J, Gillet P, Jacobs J. Malaria rapid diagnostic tests in endemic settings. Clin Microbiol Infect. 2013;19:399\u2013407.","journal-title":"Clin Microbiol Infect"},{"key":"5920_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02246-3","volume":"10","author":"Q Li","year":"2025","unstructured":"Li Q, Liu T, Lv K, Liao F, Wang J, Tu Y, et al. Malaria: past, present, and future. Signal Transduct Target Ther. 2025;10:188.","journal-title":"Signal Transduct Target Ther"},{"key":"5920_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1003452","volume":"13","author":"TJ Owalla","year":"2022","unstructured":"Owalla TJ, Hergott DEB, Seilie AM, Staubus W, Chavtur C, Chang M, et al. Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trials. Front Immunol. 2022;13:1003452.","journal-title":"Front Immunol"},{"key":"5920_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22154-8","volume":"12","author":"CM de Korne","year":"2022","unstructured":"de Korne CM, van Schuijlenburg R, Sijtsma JC, de Bes HM, Baalbergen E, Azargoshasb S, et al. Sporozoite motility as a quantitative readout for anti-CSP antibody inhibition. Sci Rep. 2022;12:17194.","journal-title":"Sci Rep"},{"key":"5920_CR14","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.19049.2","volume":"8","author":"S Sawasdichai","year":"2023","unstructured":"Sawasdichai S, Chaumeau V, Kearney E, Wasisakun P, Simpson JA, Price DJ, et al. Characterizing antibody responses to mosquito salivary antigens of the Southeast Asian vectors of malaria and dengue with a human challenge model of controlled exposure: a protocol. Wellcome Open Res. 2023;8:135.","journal-title":"Wellcome Open Res"},{"key":"5920_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fmicb.2014.00625","volume":"5","author":"JN Dups","year":"2014","unstructured":"Dups JN, Pepper M, Cockburn IA. Antibody and B cell responses to Plasmodium sporozoites. Front Microbiol. 2014;5:625.","journal-title":"Front Microbiol"},{"key":"5920_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrmicro3364","volume":"12","author":"T Bousema","year":"2014","unstructured":"Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833\u201340.","journal-title":"Nat Rev Microbiol"},{"key":"5920_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.pt.2007.08.023","volume":"23","author":"P Corran","year":"2007","unstructured":"Corran P, Coleman P, Riley E, Drakeley C. Serology: a robust indicator of malaria transmission intensity? Trends Parasitol. 2007;23:575\u201382.","journal-title":"Trends Parasitol"},{"key":"5920_CR18","first-page":"299","volume-title":"Adv Parasitol","author":"C Drakeley","year":"2009","unstructured":"Drakeley C, Cook J. Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. In: Adv Parasitol, vol. 69. 2009. p. 299\u2013352."},{"key":"5920_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12936-025-05343-4","volume":"24","author":"D Doum","year":"2025","unstructured":"Doum D, McIver DJ, Chen I, Keo V, Sovannaroth S, Lek D, et al. Asymptomatic malaria reservoirs are the last challenge in the elimination in Cambodia. Malar J. 2025;24:110.","journal-title":"Malar J"},{"key":"5920_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12936-025-05304-x","volume":"24","author":"DJ McIver","year":"2025","unstructured":"McIver DJ, Vajda EA, Doum D, Daniel NW, Quan M, Lovin DD, et al. Identifying gaps in protection from malaria vector biting in rural Cambodia using an entomological assessment and human behaviour observations. Malar J. 2025;24:96.","journal-title":"Malar J"},{"key":"5920_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12936-025-05682-2","volume":"24","author":"DJ McIver","year":"2025","unstructured":"McIver DJ, Doum D, Men C, Neukom J, Lobo NF, Richardson JH, et al. Evaluating the acceptability and feasibility of new mosquito bite prevention tools in a \u201cforest pack\u201d to support malaria elimination in Cambodia. Malar J. 2025;24:443.","journal-title":"Malar J"},{"key":"5920_CR22","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1038\/s41598-021-85628-1","volume":"11","author":"A Vantaux","year":"2021","unstructured":"Vantaux A, Riehle MM, Piv E, Farley EJ, Chy S, Kim S, et al. Anopheles ecology, genetics and malaria transmission in northern Cambodia. Sci Rep. 2021;11:6458.","journal-title":"Sci Rep"},{"key":"5920_CR23","doi-asserted-by":"publisher","first-page":"17348","DOI":"10.1038\/s41598-024-67470-3","volume":"14","author":"\u00c9A Vajda","year":"2024","unstructured":"Vajda \u00c9A, Ross A, Doum D, Fairbanks EL, Chitnis N, Hii J, et al. Field evaluation of a volatile pyrethroid spatial repellent and etofenprox treated clothing for outdoor protection against forest malaria vectors in Cambodia. Sci Rep. 2024;14:17348.","journal-title":"Sci Rep"},{"key":"5920_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12936-024-05188-3","volume":"23","author":"\u00c9A Vajda","year":"2024","unstructured":"Vajda \u00c9A, Ross A, Saeung M, Pongsiri A, McIver DJ, Tatarsky A, et al. The effect of novel mosquito bite prevention tools on Anopheles minimus landing and key secondary endpoints: semi-field evaluations in Thailand. Malar J. 2024;23:387.","journal-title":"Malar J"},{"key":"5920_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1475-2875-7-195","volume":"7","author":"PH Corran","year":"2008","unstructured":"Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, Griffin J, et al. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J. 2008;7:195.","journal-title":"Malar J"},{"key":"5920_CR26","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1093\/infdis\/jiaf274","volume":"232","author":"NK Copeland","year":"2025","unstructured":"Copeland NK, Otieno L, Otieno JD, Otieno S, Chira S, Ivinson K, et al. Efficacy of RTS,S\/AS01E only seen in baseline parasitemic and not baseline aparasitemic Plasmodium falciparum-exposed, drug-treated Kenyan adults. J Infect Dis. 2025;232:e372\u201382.","journal-title":"J Infect Dis"},{"key":"5920_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002472","volume":"3","author":"A Poinsignon","year":"2008","unstructured":"Poinsignon A, Cornelie S, Mestres-Simon M, Lanfrancotti A, Rossignol M, Boulanger D, et al. Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. PLoS ONE. 2008;3:e2472.","journal-title":"PLoS ONE"},{"key":"5920_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12864-017-3579-8","volume":"18","author":"B Arc\u00e0","year":"2017","unstructured":"Arc\u00e0 B, Lombardo F, Struchiner CJ, Ribeiro JM. Anopheline salivary protein genes and gene families: an evolutionary overview after the whole genome sequence of sixteen Anopheles species. BMC Genomics. 2017;18:153.","journal-title":"BMC Genomics"},{"key":"5920_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00541-18","author":"CE Hall","year":"2019","unstructured":"Hall CE, Hagan LM, Bergmann-Leitner E, Tosh DM, Bennett JW, Regules JA, et al. Mosquito bite-induced controlled human malaria infection with Plasmodium vivax or P. falciparum generates immune responses to homologous and heterologous preerythrocytic and erythrocytic antigens. Infect Immun. 2019. https:\/\/doi.org\/10.1128\/IAI.00541-18.","journal-title":"Infect Immun"},{"key":"5920_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101345","volume":"8","author":"J Bolton","year":"2021","unstructured":"Bolton J, Chaudhury S, MacGill RS, Early AM, King CR, Locke E, et al. Multiplex serological assay for establishing serological profiles of polymorphic, closely related peptide antigens. MethodsX. 2021;8:101345.","journal-title":"MethodsX"},{"key":"5920_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cyto.a.20823","volume":"77","author":"F Hahne","year":"2010","unstructured":"Hahne F, Khodabakhshi AH, Bashashati A, Wong CJ, Gascoyne RD, Weng AP, et al. Per-channel basis normalization methods for flow cytometry data. Cytometry A. 2010;77:121\u201331.","journal-title":"Cytometry A"},{"key":"5920_CR32","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","volume":"18","author":"W Huber","year":"2002","unstructured":"Huber W, von Heydebreck A, S\u00fcltmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18:S96\u2013104.","journal-title":"Bioinformatics"},{"key":"5920_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12864-016-2888-7","volume":"17","author":"TK Rausch","year":"2016","unstructured":"Rausch TK, Schillert A, Ziegler A, L\u00fcking A, Zucht HD, Schulz-Knappe P. Comparison of pre-processing methods for multiplex bead-based immunoassays. BMC Genomics. 2016;17:601.","journal-title":"BMC Genomics"},{"key":"5920_CR34","unstructured":"Team RC: A Language and Environment for Statistical Computing. In R Foundation for Statistical Computing, vol. 2026. Vienna, Austria: R Core team; 2025."},{"key":"5920_CR35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/21645515.2019.1654807","volume":"16","author":"S Chaudhury","year":"2020","unstructured":"Chaudhury S, Duncan EH, Atre T, Dutta S, Spring MD, Leitner WW, et al. Combining immunoprofiling with machine learning to assess the effects of adjuvant formulation on human vaccine-induced immunity. Hum Vaccin Immunother. 2020;16:400\u201311.","journal-title":"Hum Vaccin Immunother"},{"key":"5920_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35452-x","volume":"8","author":"S Chaudhury","year":"2018","unstructured":"Chaudhury S, Duncan EH, Atre T, Storme CK, Beck K, Kaba SA, et al. Identification of immune signatures of novel adjuvant formulations using machine learning. Sci Rep. 2018;8:17508.","journal-title":"Sci Rep"},{"key":"5920_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08526-5","volume":"7","author":"S Chaudhury","year":"2017","unstructured":"Chaudhury S, Regules JA, Darko CA, Dutta S, Wallqvist A, Waters NC, et al. Delayed fractional dose regimen of the RTS,S\/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis. Sci Rep. 2017;7:7998.","journal-title":"Sci Rep"},{"key":"5920_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249936","volume":"16","author":"E Kyei-Baafour","year":"2021","unstructured":"Kyei-Baafour E, Oppong M, Kusi KA, Frempong AF, Aculley B, Arthur FKN, et al. Suitability of IgG responses to multiple Plasmodium falciparum antigens as markers of transmission intensity and pattern. PLoS ONE. 2021;16:e0249936.","journal-title":"PLoS ONE"},{"key":"5920_CR39","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3201\/eid2610.202632","volume":"26","author":"M Das","year":"2020","unstructured":"Das M, Chaudhary A. A B, Wener M, Fink S, C M: Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results. Emerg Infect Dis. 2020;26:2501\u20133.","journal-title":"Emerg Infect Dis"},{"key":"5920_CR40","doi-asserted-by":"crossref","unstructured":"Galbraith MD, Kinning KT, Sullivan KD, Baxter R, Araya P, Jordan KR, Russell S, Smith KP, Granrath RE, Shaw J, et al: Seroconversion stages COVID19 into distinct pathophysiological states. medRxiv 2020.","DOI":"10.1101\/2020.12.05.20244442"},{"key":"5920_CR41","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/infdis\/jiad581","volume":"229","author":"DA Prah","year":"2024","unstructured":"Prah DA, Laryea-Akrong E. Asymptomatic low-density Plasmodium falciparum infections: parasites under the host\u2019s immune radar? J Infect Dis. 2024;229:1913\u20138.","journal-title":"J Infect Dis"},{"key":"5920_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2025.103052","volume":"107","author":"W Kagaya","year":"2025","unstructured":"Kagaya W. Low-density Plasmodium falciparum infection: \u201ceven a parasite will turn.\u201d Parasitol Int. 2025;107:103052.","journal-title":"Parasitol Int"},{"key":"5920_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2021.111425","volume":"246","author":"WL Mandala","year":"2021","unstructured":"Mandala WL, Harawa V, Dzinjalamala F, Tembo D. The role of different components of the immune system against Plasmodium falciparum malaria: possible contribution towards malaria vaccine development. Mol Biochem Parasitol. 2021;246:111425.","journal-title":"Mol Biochem Parasitol"},{"key":"5920_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105419","volume":"109","author":"R Mukhiya","year":"2024","unstructured":"Mukhiya R, Fleischmann WA, Loughland JR, Chan JA, de Labastida RF, Andrew D, et al. Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection. EBioMedicine. 2024;109:105419.","journal-title":"EBioMedicine"},{"key":"5920_CR45","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1038\/s41467-025-61462-1","volume":"16","author":"E LaVerriere","year":"2025","unstructured":"LaVerriere E, Johnson ZM, Shieh M, Nziza N, Alter G, Buckee CO, et al. Marked heterogeneity in malaria infection rate in a Malian longitudinal cohort. Nat Commun. 2025;16:6512.","journal-title":"Nat Commun"},{"key":"5920_CR46","doi-asserted-by":"crossref","unstructured":"Badu K, Boampong K, Larbi AA: Malaria Elimination: The Role and Value of Sero-Surveillance. In Current Topics and Emerging Issues in Malaria Elimination. Edited by Rodriguez-Morales AJ. London: IntechOpen; 2021","DOI":"10.5772\/intechopen.97131"},{"key":"5920_CR47","doi-asserted-by":"publisher","first-page":"e1498","DOI":"10.1016\/S2214-109X(25)00282-7","volume":"13","author":"R Reithinger","year":"2025","unstructured":"Reithinger R. The road to malaria elimination: why a robust surveillance system is imperative. Lancet Glob Health. 2025;13:e1498\u20139.","journal-title":"Lancet Glob Health"},{"key":"5920_CR48","doi-asserted-by":"publisher","first-page":"12998","DOI":"10.1038\/s41598-023-39670-w","volume":"13","author":"I Byrne","year":"2023","unstructured":"Byrne I, William T, Chua TH, Patterson C, Hall T, Tan M, et al. Serological evaluation of risk factors for exposure to malaria in a pre-elimination setting in Malaysian Borneo. Sci Rep. 2023;13:12998.","journal-title":"Sci Rep"},{"key":"5920_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009440","volume":"15","author":"B Fustec","year":"2021","unstructured":"Fustec B, Phanitchat T, Aromseree S, Pientong C, Thaewnongiew K, Ekalaksananan T, et al. Serological biomarker for assessing human exposure to Aedes mosquito bites during a randomized vector control intervention trial in northeastern Thailand. PLoS Negl Trop Dis. 2021;15:e0009440.","journal-title":"PLoS Negl Trop Dis"},{"key":"5920_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-4-192","volume":"4","author":"M Braks","year":"2011","unstructured":"Braks M, van der Giessen J, Kretzschmar M, van Pelt W, Scholte E-J, Reusken C, et al. Towards an integrated approach in surveillance of vector-borne diseases in Europe. Parasit Vectors. 2011;4:192.","journal-title":"Parasit Vectors"},{"key":"5920_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18532-2","volume":"8","author":"TTC Minuzzi-Souza","year":"2018","unstructured":"Minuzzi-Souza TTC, Nitz N, Cuba CAC, Hagstr\u00f6m L, Hecht MM, Santana C, et al. Surveillance of vector-borne pathogens under imperfect detection: lessons from Chagas disease risk (mis)measurement. Sci Rep. 2018;8:151.","journal-title":"Sci Rep"},{"key":"5920_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94656-w","volume":"11","author":"B van de Straat","year":"2021","unstructured":"van de Straat B, Russell TL, Staunton KM, Sinka ME, Burkot TR. A global assessment of surveillance methods for dominant malaria vectors. Sci Rep. 2021;11:15337.","journal-title":"Sci Rep"},{"key":"5920_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12060791","volume":"12","author":"L Kartal","year":"2023","unstructured":"Kartal L, Mueller I, Longley RJ. Using serological markers for the surveillance of Plasmodium vivax malaria: a scoping review. Pathogens. 2023;12:791.","journal-title":"Pathogens"},{"key":"5920_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12936-020-03225-5","volume":"19","author":"JS Bolton","year":"2020","unstructured":"Bolton JS, Chaudhury S, Dutta S, Gregory S, Locke E, Pierson T, et al. Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination. Malar J. 2020;19:159.","journal-title":"Malar J"},{"key":"5920_CR55","doi-asserted-by":"crossref","unstructured":"Rosado J, Han J, Obadia T, Munro J, Traore Z, Schoffer K, Brewster J, Bourke C, Vinetz JM, White M, et al: Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification. medRxiv 2025:2025.2005.2026.25327775.","DOI":"10.1101\/2025.05.26.25327775"},{"key":"5920_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2021.102492","volume":"87","author":"Y Tayipto","year":"2022","unstructured":"Tayipto Y, Liu Z, Mueller I, Longley RJ. Serology for Plasmodium vivax surveillance: a novel approach to accelerate towards elimination. Parasitol Int. 2022;87:102492.","journal-title":"Parasitol Int"},{"key":"5920_CR57","doi-asserted-by":"publisher","DOI":"10.12688\/gatesopenres.12897.1","volume":"3","author":"B Greenhouse","year":"2019","unstructured":"Greenhouse B, Daily J, Guinovart C, Goncalves B, Beeson J, Bell D, et al. Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination. Gates Open Res. 2019;3:131.","journal-title":"Gates Open Res"},{"key":"5920_CR58","doi-asserted-by":"publisher","DOI":"10.12703\/P6-100","volume":"6","author":"SR Elliott","year":"2014","unstructured":"Elliott SR, Fowkes FJ, Richards JS, Reiling L, Drew DR, Beeson JG. Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep. 2014;6:100.","journal-title":"F1000Prime Rep"},{"key":"5920_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259131","volume":"16","author":"NA Kassam","year":"2021","unstructured":"Kassam NA, Kulaya N, Kaaya RD, Schmiegelow C, Wang CW, Kavishe RA, et al. Use of anti-gSG6-P1 IgG as a serological biomarker to assess temporal exposure to Anopheles\u2019 mosquito bites in Lower Moshi. PLoS ONE. 2021;16:e0259131.","journal-title":"PLoS ONE"},{"key":"5920_CR60","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/insects6040961","volume":"6","author":"S Doucoure","year":"2015","unstructured":"Doucoure S, Drame PM. Salivary biomarkers in the control of mosquito-borne diseases. Insects. 2015;6:961\u201376.","journal-title":"Insects"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05920-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05920-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05920-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:02:51Z","timestamp":1780988571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05920-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5920"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05920-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}